Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France

Valentine Brousse, MD PhD, Cécile Arnaud, MD, Emmanuelle Lesprit, MD, Marie-Helene Odièvre-Montanié, MD PhD, Maryse Etienne-Julan, MD, Gisele Elana, MD, Marie Belloy, MD, Cecile Dumesnil, MD, Beatrice Quinet, MD, Abdourahim Chamouine, MD, Cecile Guillaumat, MD, Nathalie Garnier, MD, Corinne Pondarré, MD PhD, Nathalie Couque, PharmD, Francoise Bernaudin, MD, Mariane de Montalembert, MD PhD, Emmanuelle Boutin, MD, Malika Benkerrou, MD, Isabelle Thuret, MD

Blood (2019) 134 (Supplement_1): 1001.

https://doi.org/10.1182/blood-2019-127221

Published: 2019

Journal Articles

A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients

Blood (2018) 132 (Supplement 1): 3652.

https://doi.org/10.1182/blood-2018-99-112296

Published: 2018

Journal Articles

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Gloria Contreras-Yametti, MD, Custodio Haidee, MD, Hamayun Imran, MD MSc

Blood (2018) 132 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2018-99-111362

Published: 2018

Journal Articles

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Ofelia A. Alvarez, MD, Tally Hustace, ARNP, Mimose Voltaire, RN, Rodrigueson Rizil, Ulrick Liberus, Rony Saint Fleur, MD

Blood (2018) 132 (Supplement 1): 3670.

https://doi.org/10.1182/blood-2018-99-115384

Published: 2018

Journal Articles

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Alexander Roeth, MD, Scott T. Rottinghaus, MD, Anita Hill, MBChB (Hons), PhD, Jin Seok Kim, MD PhD, Hubert Schrezenmeier, MD, Louis Terriou, MD, Alvaro Urbano-Ispizua, MD, Richard A. Wells, MD DPhil, Jun Ho Jang, MD PhD, Jeff Szer, MB, BS, FRACP, Rasha Aguzzi, MS, Eric Scott Bachman, MD PhD, Andrew I. Damokosh, PhD, Lori Shafner, PhD, Jong-Wook Lee, MD

Blood (2017) 130 (Supplement 1): 3482.

https://doi.org/10.1182/blood.V130.Suppl_1.3482.3482

Published: 2017

Journal Articles

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Frédéric Galactéros, MDPhD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD, Corinne Pondarré, MD PhD, Jean Benoît Arlet, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Lena Oevermann, MD, Stephan Lobitz, MD

Blood (2017) 130 (Supplement 1): 3543.

https://doi.org/10.1182/blood.V130.Suppl_1.3543.3543

Published: 2017

Journal Articles

Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti

Rose Mintor, Steve Morisseau, Romain Jean Louis, Marlene Damas Borgella, Christophe Milien, Marc Julmisse, Joseph Ubaike, Chris Wong, Michelle Niescierenko, Natasha Archer, MD

Blood (2017) 130 (Supplement 1): 3353.

https://doi.org/10.1182/blood.V130.Suppl_1.3353.3353

Published: 2017

Journal Articles

Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab: a Series of 8 Cases

Mihee Park, MD BS, Ilene Ceil Weitz, MD

Blood (2017) 130 (Supplement 1): 1043.

https://doi.org/10.1182/blood.V130.Suppl_1.1043.1043

Published: 2017

Journal Articles

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Dania Monagel, MDFRCPC,FAAP, Michael Leaker, MDFRCPC, Doan Le, MDFRCPC,FAAP, Nicola A. Wright, MSc, MD FRCPC, Angela Ruzycki, MacGregor Steele, MD FRCPC

Blood (2017) 130 (Supplement 1): 2255.

https://doi.org/10.1182/blood.V130.Suppl_1.2255.2255

Published: 2017

Journal Articles

Novel Use of Hydroxyurea in an African Region with Malaria (NOHARM): A Randomized Controlled Trial

Robert Opoka, Christopher Ndugwa, MMED, Teresa S. Latham, Adam Lane, Heather Ann Hume, MDFRCPC, Philip Kasirye, MD, James L Hodges, PhD, Russell E. Ware, MD PhD, Chandy C John, MD

Blood (2017) 130 (Supplement 1): 759.

https://doi.org/10.1182/blood.V130.Suppl_1.759.759

Published: 2017

Journal Articles

Mortality Trends and Causes of Death in Persons with Sickle Cell Disease in the United States, 1979-2014

Amanda B. Payne, MPH, Jason M. Mehal, MSPH, Christina Chapman, MSPH, Dana L. Haberling, MSPH, Lisa C. Richardson, MDMPH, Christopher J. Bean, PhD, William C. Hooper, PhD

Blood (2017) 130 (Supplement 1): 865.

https://doi.org/10.1182/blood.V130.Suppl_1.865.865

Published: 2017

Journal Articles

Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial)

Najibah Aliyu Galadanci, MBBS MPH, Shehu Umar Abdullahi, MBBS, Leah Danielle Vance, BS, Musa Tabari, MBBS, Shehi Abubakar, MBBS, Belonwu Raymond, MBBS, Salihu Auwal, MBBS, Aisha Amal Galadanci, MBBS, Binta WUDIL Jibir, MBBS MPH, Halima Bello-Manga, MBBS, MPH, Kathleen A Neville, MD MS, Fenella Kirkham, MD, Yu Shyr, MD, Sharon E. Phillips, MSPH, Brittany Covert, MPH, CCRP, Adetola A. Kassim, MD MS, Lori Jordan, MD, Muktar Aliyu, MD PhD, Michael DeBaun, MD

Blood (2016) 128 (22): 122.

https://doi.org/10.1182/blood.V128.22.122.122

Published: 2016

Journal Articles

Evaluation of a Novel Newborn Screening Follow-up Program for Infants with Sickle Cell Disease

Emily Riehm Meier, MD MSHS, Kisha Hampton, MPH, Ellen Bloom, MPH, CHES, Natalie Duncan, MPH, Chris Roberson, JD, MPH, Angeli Rampersad, MD

Blood (2016) 128 (22): 2344.

https://doi.org/10.1182/blood.V128.22.2344.2344

Published: 2016

Journal Articles

Outcomes of Fever in Infants and Young Children with SCD Presenting to the Emergency Room

Krishnaveni Sirigaddi, MBBS, Inmaculada Aban, PhD, Christina J. Bemrich-Stolz, MDMSPH, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 3591.

https://doi.org/10.1182/blood.V128.22.3591.3591

Published: 2016

Journal Articles

Outcomes of Splenectomy in Children with Sickle Cell Disease

Peter B. Soh, M.P.H., Abdul H. Siddiqui, MBBS, MD

Blood (2014) 124 (21): 1382.

https://doi.org/10.1182/blood.V124.21.1382.1382

Published: 2014

Journal Articles

Survival into Adulthood in Sickle Cell Disease from the Dallas Newborn Cohort

Melissa D. Mathias, MD, Song Zhang, PhD, Zora R. Rogers, MD, George R. Buchanan, MD, Alecia C. Nero, MD, Timothy L. McCavit, MD MS

Blood (2014) 124 (21): 559.

https://doi.org/10.1182/blood.V124.21.559.559

Published: 2014

Journal Articles

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Patrick T. McGann, MD, Margarida Muhongo, Elizabeth McGann, Vysolela de Oliveira, Brigida Santos, MD, Russell E. Ware, MD, PhD

Blood (2013) 122 (21): 2934.

https://doi.org/10.1182/blood.V122.21.2934.2934

Published: 2013

Journal Articles

Determinants Of Mortality and Survival In Children With Sickle Cell Disease (SCD) In Sub Saharan Africa

Tom Adamkiewicz, MD, MSCR, FRCP(C), Adel Driss, PhD, MSc, BSc, Hyacinth I Hyacinth, MBBS, MPH, Jacqueline Hibbert, PhD, Jonathan K Stiles, PhD

Blood (2013) 122 (21): 4676.

https://doi.org/10.1182/blood.V122.21.4676.4676

Published: 2013

Journal Articles

Cost-Effectiveness Of Neonatal Screening For Sickle Cell Disease In The Republic Of Angola

Patrick T. McGann, MD, Brigida Santos, MD, Vysolela de Oliveira, Luis Bernardino, MD, Russell E. Ware, MD, PhD, Scott D Grosse, PhD

Blood (2013) 122 (21): 421.

https://doi.org/10.1182/blood.V122.21.421.421

Published: 2013

Journal Articles

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Mariane De Montalembert, MD, Miguel R. Abboud, MD, Anne Fiquet, MD, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, Normeen Kaddah, MD, Antonio Piga, MD, Baba Inusa, MD, Qin Jiang, MS, Lisa Pereira, BSc, Emilio A. Emini, PhD, William C. Gruber, MD, Alejandra Gurtman, MD, Daniel A. Scott, MD

Blood (2012) 120 (21): 3212.

https://doi.org/10.1182/blood.V120.21.3212.3212

Published: 2012

NARROW

Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed By Newborn Screening: A Real-World Nation-Wide Study in France

A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti

Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab: a Series of 8 Cases

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Novel Use of Hydroxyurea in an African Region with Malaria (NOHARM): A Randomized Controlled Trial

Mortality Trends and Causes of Death in Persons with Sickle Cell Disease in the United States, 1979-2014

Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial)

Evaluation of a Novel Newborn Screening Follow-up Program for Infants with Sickle Cell Disease

Outcomes of Fever in Infants and Young Children with SCD Presenting to the Emergency Room

Outcomes of Splenectomy in Children with Sickle Cell Disease

Survival into Adulthood in Sickle Cell Disease from the Dallas Newborn Cohort

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Determinants Of Mortality and Survival In Children With Sickle Cell Disease (SCD) In Sub Saharan Africa

Cost-Effectiveness Of Neonatal Screening For Sickle Cell Disease In The Republic Of Angola

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only